Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/G l ucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions

被引：0
作者：
Alicic, Radica Z. [1 ,2 ]
Neumiller, Joshua J. [3 ]
机构：
[1] Providence Inland Northwest Hlth, Providence Med Res Ctr, Spokane, WA USA
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmacotherapy, 412 E Spokane Falls Blvd, Spokane, WA 99210 USA
来源：
CARDIOLOGY CLINICS | 2025年 / 43卷 / 03期
关键词：
Cardiovascular outcome trials; Dulaglutide; Exenatide; Incretin hormones; Liraglutide; Pathomechanisms; Semaglutide; Tirzepatide; ELEVATION MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; TYPE-2 DIABETES PATIENTS; HEART-FAILURE; DOUBLE-BLIND; GLP-1; LIRAGLUTIDE; INCRETIN; EXENATIDE; OUTCOMES;
D O I：
10.1016/j.ccl.2024.12.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：415 / 432
页数：18
相关论文
共 104 条
[1]   Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease [J].
Alicic, Radica Z. ;
Neumiller, Joshua J. ;
Tuttle, Katherine R. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2023, 32 (04) :377-385
[2]   Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence [J].
Alicic, Radica Z. ;
Cox, Emily J. ;
Neumiller, Joshua J. ;
Tuttle, Katherine R. .
NATURE REVIEWS NEPHROLOGY, 2021, 17 (04) :227-244
[3]   Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial [J].
Alkhouri, Naim ;
Herring, Robert ;
Kabler, Heidi ;
Kayali, Zeid ;
Hassanein, Tarek ;
Kohli, Anita ;
Huss, Ryan S. ;
Zhu, Yanni ;
Billin, Andrew N. ;
Damgaard, Lars Holm ;
Buchholtz, Kristine ;
Kjaer, Mette Skalshoi ;
Balendran, Clare ;
Myers, Robert P. ;
Loomba, Rohit ;
Noureddin, Mazen .
JOURNAL OF HEPATOLOGY, 2022, 77 (03) :607-618
[4]   Targeting the incretin system in obesity and type 2 diabetes mellitus [J].
Ansari, Saleem ;
Khoo, Bernard ;
Tan, Tricia .
NATURE REVIEWS ENDOCRINOLOGY, 2024, 20 (08) :447-459
[5]   Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart [J].
Aravindhan, Karpagam ;
Bao, Weike ;
Harpel, Mark R. ;
Willette, Robert N. ;
Lepore, John J. ;
Jucker, Beat M. .
PLOS ONE, 2015, 10 (06)
[6]   Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes [J].
Bagger, Jonatan I. ;
Knop, Filip K. ;
Lund, Asger ;
Vestergaard, Henrik ;
Holst, Jens J. ;
Vilsboll, Tina .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) :737-745
[7]   GLP-1 Receptor Expression Within the Human Heart [J].
Baggio, Laurie L. ;
Yusta, Bernardo ;
Mulvihill, Erin E. ;
Cao, Xiemin ;
Streutker, Catherine J. ;
Butany, Jagdish ;
Cappola, Thomas P. ;
Margulies, Kenneth B. ;
Drucker, Daniel J. .
ENDOCRINOLOGY, 2018, 159 (04) :1570-1584
[8]   Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors [J].
Balks, HJ ;
Holst, JJ ;
vonzurMuhlen, A ;
Brabant, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :786-790
[9]   Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency [J].
Bao, Weike ;
Aravindhan, Karpagam ;
Alsaid, Hasan ;
Chendrimada, Thimmaiah ;
Szapacs, Matthew ;
Citerone, David R. ;
Harpel, Mark R. ;
Willette, Robert N. ;
Lepore, John J. ;
Jucker, Beat M. .
PLOS ONE, 2011, 6 (08)
[10]   Heart Failure With Preserved Ejection Fraction [J].
Borlaug, Barry A. ;
Sharma, Kavita ;
Shah, Sanjiv J. ;
Ho, Jennifer E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) :1810-1834
12345678910